
IFCI Q1 Results FY26: Q1 PAT Soars 136.92% to ₹39.95 Crore; Revenue Up 5.00% YoY
Q1 Results FY26
Updated: 11 Aug 2025 • 3:43 pm
Posted by:

IFCI Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹407.18 | ₹387.80 |
| Profit Before Tax (PBT) | ₹230.28 | ₹194.99 |
| Profit After Tax (PAT) | ₹39.95 | -₹108.20 |
(Figures in crores)
IFCI Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹155.51 | ₹122.38 |
| Profit Before Tax (PBT) | ₹138.59 | ₹104.22 |
| Profit After Tax (PAT) | ₹7.38 | -₹148.24 |
(Figures in crores)
IFCI Q1 Results FY26 Highlights (Q1 FY26 vs FY25)
- IFCI clocked Q1 FY26 consolidated revenue of ₹407.18 crores vs ₹387.80 crores.
- On the profit front, IFCI earned a consolidated PAT of ₹39.95 crore in Q1 FY26. During FY25, the company’s PAT stood at -₹108.20 crore.
- Consolidated PAT rose for the first quarter of FY26, was 136.92% YoY, and revenue rose 5.00% YoY.
- As per the standalone figures, the quarterly PAT of IFCI has increased by 104.98%, and revenue has increased by 27.07% YoY.
IFCI Share Price Performance
On the opening bell of 11th August 2025, the shares of IFCI opened at ₹53.01 per share. However, the initial gains are wiped out as of now, and IFCI shares are trading at ₹52.40 per share, higher than their opening price.
Considering the long-term performance, IFCI shares have yielded close to -29.36% returns in the past 1 year, and 5-year returns stand at 638.31%. Over the maximum timeframe, the IFCI share provided 211.34% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in IFCI shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Also Read : Glenmark Life Sciences Q1 Results FY26: Q1 PAT Rises 9.02% to ₹121.54 Crore; Revenue Surged 2.25% YoY
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
JSW Cement IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?
Recent Articles

Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
29 May 2026

Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
29 May 2026

Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
29 May 2026

Jetking Infotrain Q4 FY26 Results: Revenue Rs 4.67 Crore, Net Profit Rs 3.43 Crore and Key Highlights
29 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
Jetking Infotrain Q4 FY26 Results: Revenue Rs 4.67 Crore, Net Profit Rs 3.43 Crore and Key Highlights
Karma Energy Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Popular this week
Vivimed Labs Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights
Aditya Ultra Steel Q4 FY26 Results: Revenue Rs 409.9 Crore, Net Profit Rs 4.02 Crore and Key Highlights
Shelter Pharma Q4 FY26 Results: Revenue Rs 39.84 Crore, Net Profit Rs 9.03 Crore and Key Highlights
Jetking Infotrain Q4 FY26 Results: Revenue Rs 4.67 Crore, Net Profit Rs 3.43 Crore and Key Highlights
Karma Energy Q4 FY26 Results: Net Loss Rs 0.06 Crore, Revenue and Key Financial Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





